QUIDELORTHO CORP Other Nonoperating Income (Expense)
QUIDELORTHO CORP (QDEL) reported Other Nonoperating Income (Expense) of -$4.70 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-07
- QUIDELORTHO CORP other nonoperating income (expense) for the quarter ending 2026-06-28 was -$4.70M.
- QUIDELORTHO CORP other nonoperating income (expense) for the quarter ending 2026-03-29 was $3.40M.
- QUIDELORTHO CORP other nonoperating income (expense) for the quarter ending 2025-12-28 was $4.90M, a 4800.00% increase year-over-year.
- QUIDELORTHO CORP other nonoperating income (expense) for the quarter ending 2025-09-28 was -$900.00K.
- QUIDELORTHO CORP other nonoperating income (expense) for fiscal 2025 was -$5.80M.
- QUIDELORTHO CORP other nonoperating income (expense) for fiscal 2024 was -$7.10M.
- QUIDELORTHO CORP other nonoperating income (expense) for fiscal 2023 was -$20.60M.
- QUIDELORTHO CORP other nonoperating income (expense) for fiscal 2023 was -$8.10M, a 8200.00% decline from fiscal 2022.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$4.70M 10-Q · filed 2026-08-07 | -$1.30M 10-Q · filed 2026-08-07 | $3.60M derived: sum of 3 quarters · filed 2026-08-07 | $2.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $3.40M 10-Q · filed 2026-05-06 | $8.30M derived: sum of 2 quarters · filed 2026-05-06 | $7.40M derived: sum of 3 quarters · filed 2026-05-06 | -$1.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.00M derived: sum of 2 quarters · filed 2026-02-19 | -$4.40M derived: sum of 3 quarters · filed 2026-08-07 | -$5.80M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$900.00K 10-Q · filed 2025-11-06 | -$9.30M derived: sum of 2 quarters · filed 2026-08-07 | -$10.70M 10-Q · filed 2025-11-06 | -$10.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | -$8.40M 10-Q · filed 2026-08-07 | -$9.80M 10-Q · filed 2026-08-07 | -$9.70M derived: sum of 3 quarters · filed 2026-08-07 | -$10.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | -$1.40M 10-Q · filed 2026-05-06 | -$1.30M derived: sum of 2 quarters · filed 2026-05-06 | -$2.20M derived: sum of 3 quarters · filed 2026-05-06 | -$6.60M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$800.00K derived: sum of 2 quarters · filed 2026-02-19 | -$5.20M derived: sum of 3 quarters · filed 2026-02-19 | -$7.10M 10-K · filed 2026-02-19 |
| 2024-09-29 | -$900.00K 10-Q · filed 2025-11-06 | -$5.30M derived: sum of 2 quarters · filed 2025-11-06 | -$7.20M 10-Q · filed 2025-11-06 | -$19.80M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$4.40M 10-Q · filed 2025-08-06 | -$6.30M 10-Q · filed 2025-08-06 | -$18.90M derived: sum of 3 quarters · filed 2026-02-19 | -$23.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$1.90M 10-Q · filed 2025-05-08 | -$14.50M derived: sum of 2 quarters · filed 2026-02-19 | -$18.60M derived: sum of 3 quarters · filed 2026-02-19 | -$19.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$12.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$16.70M derived: sum of 2 quarters · filed 2026-02-19 | -$17.70M derived: sum of 3 quarters · filed 2026-02-19 | -$20.60M 10-K · filed 2026-02-19 |
| 2023-10-01 | -$4.10M 10-Q · filed 2024-11-08 | -$5.10M derived: sum of 2 quarters · filed 2024-11-08 | -$8.00M 10-Q · filed 2024-11-08 | -$18.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$1.00M 10-Q · filed 2024-08-01 | -$3.90M 10-Q · filed 2024-08-01 | -$14.60M derived: sum of 3 quarters · filed 2025-02-27 | -$10.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | -$2.90M 10-Q · filed 2024-05-09 | -$13.60M derived: sum of 2 quarters · filed 2025-02-27 | -$9.40M derived: sum of 3 quarters · filed 2025-02-27 | -$11.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | -$10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$6.50M derived: sum of 2 quarters · filed 2025-02-27 | -$9.00M derived: sum of 3 quarters · filed 2025-02-27 | -$8.10M 10-K · filed 2025-02-27 |
| 2022-10-02 | $4.20M 10-Q · filed 2023-11-02 | $1.70M derived: sum of 2 quarters · filed 2023-11-02 | $2.60M 10-Q · filed 2023-11-02 | $2.30M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | -$2.50M 10-Q · filed 2023-08-09 | -$1.60M 10-Q · filed 2023-08-09 | -$1.90M derived: sum of 3 quarters · filed 2024-08-01 | -$900.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $900.00K 10-Q · filed 2023-05-04 | $600.00K derived: sum of 2 quarters · filed 2024-08-01 | $1.60M derived: sum of 3 quarters · filed 2024-08-01 | $1.40M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-01-02 | -$300.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $700.00K derived: sum of 2 quarters · filed 2024-08-01 | $500.00K derived: sum of 3 quarters · filed 2024-08-01 | $100.00K 10-K/A · filed 2024-08-01 |
| 2021-10-03 | $1.00M 10-Q · filed 2022-11-04 | $800.00K derived: sum of 2 quarters · filed 2022-11-04 | $400.00K 10-Q · filed 2022-11-04 | |
| 2021-07-04 | -$200.00K 10-Q · filed 2022-08-05 | -$600.00K 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | -$1.10M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |